Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein O pseudogene 5 (APOOP5) is a processed, transcriptionally active pseudogene derived from apolipoprotein O (APOO). Although pseudogenes have traditionally been considered non-functional, some—including APOOP5—may have regulatory activity at the RNA level, influencing the expression and function of their parent genes. Recent research indicates that a variant in APOOP5 is associated with increased LDL cholesterol in certain populations, possibly via interaction and regulatory influence upon APOO. However, unlike APOO, APOOP5 does not produce a functional protein and therefore is not considered a classical therapeutic target[5][3]. If you are seeking structured data or druggability, focus on the parent gene/protein, Apolipoprotein O (APOO), as APOOP5 itself is primarily relevant for genetics and regulatory studies rather than direct molecular targeting[5][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein O pseudogene 5 (APOOP5).